ClickHouse Extends Series C Financing and Expands Leadership Team to Fuel Growth
7.10.2025 15:00:00 CEST | Business Wire | Press Release
ClickHouse, a leader in real-time analytics, data warehousing, observability, and AI/ML, today announced an extension of its Series C financing and related transactions. New investors Citi Ventures, Insight Partners, Peak XV Partners, Founders Circle Capital, D. E. Shaw Ventures, Adams Street Partners, Rosberg Ventures, Expanding Capital, and notable individuals such as 49ers Brock Purdy, Christian McCaffrey, and Kyle Juszczyk joined the round, with continued participation from existing investors Altimeter, Bessemer Venture Partners, IVP, BOND, and GIC.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251007292299/en/
ClickHouse co-founders (from left to right): Yury Izrailevsky, Aaron Katz, Alexey Milovidov
The company has surpassed 2,000 customers and more than quadrupled ARR over the past year. Customer adoption has surged, with new wins including Cyera, Hewlett Packard Enterprise, Insider, Laravel, Masorange, Qualified, Shopmonkey, and Supabase, while long-term customers such as Canva, Harvey, LangChain, Perion, and SonyLIV extended their contracts. Adoption has been especially strong among AI companies, with Anthropic, LangChain, Meta, Sierra, Vercel, and Weights & Biases joining the roster of companies running business-critical systems on ClickHouse Cloud.
Recognition of the company’s momentum has also continued to grow. ClickHouse was named to the 2025 Forbes Cloud 100 list, underscoring its position as one of the most innovative and fast-growing private cloud companies. The company hosted its inaugural user conference, OpenHouse, which brought together customers and partners, including OpenAI, Anthropic, and Tesla. The event featured keynote presentations, product demonstrations, and customer success stories, highlighting how ClickHouse is powering AI and analytics initiatives across industries. Building on that energy, ClickHouse will once again host its AWS re:Invent party, “HouseParty, the SQL,” headlined by The Chainsmokers.
The company bolstered its leadership team with three key hires. In July, Kevin Egan joined as Chief Revenue Officer, bringing more than two decades of enterprise sales leadership with senior roles at Atlassian, Slack, Dropbox, and Salesforce. In August, Mariah Nagy came on board as Vice President of People, bringing deep experience leading people teams at high-growth companies including Weights & Biases, Confluent, and SurveyMonkey. Most recently, Jimmy Sexton joined as Chief Financial Officer, bringing extensive finance leadership experience from Snowflake and ServiceNow.
ClickHouse continues to advance its platform across multiple use cases:
- The company launched ClickStack, a high-performance observability stack that unifies logs, metrics, traces, and session replays into a single platform.
- For real-time analytics workloads, ClickHouse added MongoDB Change Data Capture (CDC), enabling seamless integration of MongoDB data streams with ClickHouse for analytics.
- For data warehousing, enhancements to data lake support improve read and write operations and optimize performance for Iceberg and Delta Lake.
- To enable building agent-facing applications, ClickHouse introduced the MCP Server endpoint and AskAI Assistant in ClickHouse Cloud, giving developers and teams the tools to quickly deploy intelligent, interactive AI-driven experiences on top of ClickHouse data.
- Across all these use cases, the database continues to evolve with improvements in vector search, JSON support, and full-text search.
- Recognizing the needs of regulated environments, ClickHouse announced ClickHouse Private, a private cloud version of its commercial offering, with ClickHouse Government adding FIPS compliance for the most highly regulated environments.
“We are incredibly grateful for the continued confidence and support from our investors,” said Aaron Katz, CEO of ClickHouse. “This extended Series C financing will accelerate our mission to empower organizations with lightning-fast analytics on massive datasets. Our data platform gives customers the speed, flexibility, and efficiency they need to tackle their most critical use cases at scale, helping them unlock value faster in the era of AI.”
“ClickHouse is transforming how companies use data,” said Vibhor Rastogi, head of AI investing at Citi Ventures. “The demand for fast, interactive analytics has never been greater, especially as data-driven AI initiatives accelerate. We believe ClickHouse is uniquely positioned to lead this market, and we’re excited to support the team as they continue scaling their platform, expanding their product capabilities, and helping customers unlock new value from their data.”
“Analytics is at the core of our products,” said Yotam Segev, Co-Founder & CEO at Cyera. “ClickHouse Cloud gives us the speed and scale to analyze massive volumes of security data directly within our platform. That foundation not only strengthens our customers’ ability to manage and reduce risk today, but also enables us to power new AI-driven capabilities that make threat prevention, detection, and response faster and more effective.”
About ClickHouse
ClickHouse is a fast, open-source columnar database management system built for real-time data processing and analytics at scale. Engineered for high performance, ClickHouse Cloud delivers exceptional query speed and concurrency, making it ideal for applications that demand instant insight from massive volumes of data. As AI agents become increasingly embedded in software and are generating far more frequent and complex queries, ClickHouse brings a high-throughput, low-latency engine, purpose-built to meet this challenge. Trusted by leading companies like Sony, Tesla, Anthropic, Memorial Sloan Kettering, Lyft, and Instacart, ClickHouse helps teams unlock insights and drive smarter decisions with a scalable, efficient, and modern data platform. For more information, visit clickhouse.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251007292299/en/
Contacts
Tanya Bragin
VP, Product & Marketing
press@clickhouse.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom